NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT03912831 2023-12-26Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ CancersGilead SciencesPhase 1 Terminated8 enrolled 13 charts
NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT01081808 2015-03-25Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsRoger Williams Medical CenterPhase 1 Terminated2 enrolled
NCT01404702 2014-12-02Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric NeuroblastomaUniversity of Alabama at BirminghamPhase 1 Terminated4 enrolled
NCT00329368 2012-03-09Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerEndocytePhase 1 Completed13 enrolled